HEADER BLOOD CLOTTING 20-MAY-02 1LTJ TITLE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE TITLE 2 PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG-PRO-AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBRINOGEN ALPHA/ALPHA-E CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: FRAGMENT D (RESIDUES 126-191); COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: FIBRINOGEN BETA CHAIN; COMPND 8 CHAIN: B, E; COMPND 9 FRAGMENT: FRAGMENT D (RESIDUES 149-461); COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: FIBRINOGEN GAMMA CHAIN; COMPND 13 CHAIN: C, F; COMPND 14 FRAGMENT: FRAGMENT D (RESIDUES 96-406); COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: GLY-PRO-ARG-PRO; COMPND 18 CHAIN: G, I; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 5; COMPND 21 MOLECULE: GLY-HIS-ARG-PRO; COMPND 22 CHAIN: H, J; COMPND 23 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO CELLS; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: CHO CELLS; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 24 EXPRESSION_SYSTEM_CELL_LINE: CHO CELLS; SOURCE 25 MOL_ID: 4; SOURCE 26 SYNTHETIC: YES; SOURCE 27 MOL_ID: 5; SOURCE 28 SYNTHETIC: YES KEYWDS BLOOD COAGULATION, FIBRINOGEN, FIBRINOGEN FRAGMENT D, RECOMBINANT KEYWDS 2 FIBRINOGEN FRAGMENT D, RECOMBINANT FIBRINOGEN, RECOMBINANT KEYWDS 3 FIBRINOGEN FRAGMENT D WITH TWO PEPTIDE LIGANDS, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR M.S.KOSTELANSKY,L.BETTS,O.V.GORKUN,S.T.LORD REVDAT 4 29-JUL-20 1LTJ 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1LTJ 1 VERSN REVDAT 2 24-FEB-09 1LTJ 1 VERSN REVDAT 1 06-NOV-02 1LTJ 0 JRNL AUTH M.S.KOSTELANSKY,L.BETTS,O.V.GORKUN,S.T.LORD JRNL TITL 2.8 A CRYSTAL STRUCTURES OF RECOMBINANT FIBRINOGEN FRAGMENT JRNL TITL 2 D WITH AND WITHOUT TWO PEPTIDE LIGANDS: GHRP BINDING TO THE JRNL TITL 3 "B" SITE DISRUPTS ITS NEARBY CALCIUM-BINDING SITE. JRNL REF BIOCHEMISTRY V. 41 12124 2002 JRNL REFN ISSN 0006-2960 JRNL PMID 12356313 JRNL DOI 10.1021/BI0261894 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 46668 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2364 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6876 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 376 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10563 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 72.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.99000 REMARK 3 B22 (A**2) : -4.62000 REMARK 3 B33 (A**2) : -6.36000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 33.05 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LTJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016258. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC CONFOCAL BLUE MULTILAYER REMARK 200 OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46717 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 18.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12300 REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39300 REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FZC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7% PEG 3350, 12.5MM CALCIUM CHLORIDE, REMARK 280 2MM SODIUM AZIDE, 50MM TRIS PH 8.5, 2MM GHRP-AMIDE, 2MM GPRP- REMARK 280 AMIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.64200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 113.46800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.10900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 113.46800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.64200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.10900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -74.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, G, H, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F, I, J, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 191 REMARK 465 HIS B 149 REMARK 465 GLN B 150 REMARK 465 LEU B 151 REMARK 465 TYR B 152 REMARK 465 ILE B 153 REMARK 465 ASP B 154 REMARK 465 GLU B 155 REMARK 465 THR B 156 REMARK 465 VAL B 157 REMARK 465 ASN B 158 REMARK 465 SER B 159 REMARK 465 ASN B 160 REMARK 465 PRO B 459 REMARK 465 GLN B 460 REMARK 465 GLN B 461 REMARK 465 GLY C 395 REMARK 465 GLU C 396 REMARK 465 GLY C 397 REMARK 465 GLN C 398 REMARK 465 GLN C 399 REMARK 465 HIS C 400 REMARK 465 HIS C 401 REMARK 465 LEU C 402 REMARK 465 GLY C 403 REMARK 465 GLY C 404 REMARK 465 ALA C 405 REMARK 465 LYS C 406 REMARK 465 VAL D 126 REMARK 465 ILE D 127 REMARK 465 GLU D 128 REMARK 465 LYS D 129 REMARK 465 VAL D 130 REMARK 465 GLN D 131 REMARK 465 HIS D 132 REMARK 465 LYS D 191 REMARK 465 HIS E 149 REMARK 465 GLN E 150 REMARK 465 LEU E 151 REMARK 465 TYR E 152 REMARK 465 ILE E 153 REMARK 465 ASP E 154 REMARK 465 GLU E 155 REMARK 465 THR E 156 REMARK 465 VAL E 157 REMARK 465 ASN E 158 REMARK 465 SER E 159 REMARK 465 ASN E 160 REMARK 465 ILE E 161 REMARK 465 PRO E 162 REMARK 465 THR E 163 REMARK 465 ASN E 164 REMARK 465 PRO E 459 REMARK 465 GLN E 460 REMARK 465 GLN E 461 REMARK 465 TYR F 96 REMARK 465 GLU F 97 REMARK 465 ALA F 98 REMARK 465 SER F 99 REMARK 465 ILE F 100 REMARK 465 LEU F 101 REMARK 465 THR F 102 REMARK 465 HIS F 103 REMARK 465 ASP F 104 REMARK 465 SER F 105 REMARK 465 SER F 106 REMARK 465 ILE F 107 REMARK 465 ARG F 108 REMARK 465 TYR F 109 REMARK 465 GLY F 395 REMARK 465 GLU F 396 REMARK 465 GLY F 397 REMARK 465 GLN F 398 REMARK 465 GLN F 399 REMARK 465 HIS F 400 REMARK 465 HIS F 401 REMARK 465 LEU F 402 REMARK 465 GLY F 403 REMARK 465 GLY F 404 REMARK 465 ALA F 405 REMARK 465 LYS F 406 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 127 -175.31 -64.63 REMARK 500 SER A 164 -53.37 -124.13 REMARK 500 PRO B 162 -100.04 -50.08 REMARK 500 ASP B 230 146.04 -174.85 REMARK 500 SER B 231 -26.88 -36.84 REMARK 500 SER B 232 -84.17 -51.77 REMARK 500 GLU B 245 64.26 39.73 REMARK 500 GLN B 256 -26.31 -158.50 REMARK 500 ASP B 281 108.16 68.45 REMARK 500 TRP B 317 5.69 -65.76 REMARK 500 ASN B 333 -176.77 -65.14 REMARK 500 MET B 367 0.25 -62.35 REMARK 500 ARG B 380 95.93 -164.32 REMARK 500 PRO B 390 8.86 -60.15 REMARK 500 LYS B 392 57.95 -98.65 REMARK 500 ASP B 398 -14.28 73.99 REMARK 500 ASN B 405 -84.82 -110.75 REMARK 500 ARG B 406 64.46 -163.24 REMARK 500 ASP B 432 59.79 -101.07 REMARK 500 VAL B 435 76.20 -53.61 REMARK 500 TRP B 437 81.05 -152.04 REMARK 500 ASN B 439 0.40 -51.34 REMARK 500 TRP B 440 -49.50 -131.57 REMARK 500 ARG B 455 146.81 -170.19 REMARK 500 PHE B 457 -82.90 -79.53 REMARK 500 GLU C 97 84.45 86.53 REMARK 500 ASP C 185 -169.45 -77.86 REMARK 500 LEU C 198 -0.93 -173.13 REMARK 500 ASP C 199 -10.51 -167.91 REMARK 500 SER C 240 119.44 -30.73 REMARK 500 ALA C 241 70.36 38.78 REMARK 500 ASP C 285 13.32 -62.68 REMARK 500 ASN C 317 82.91 -163.90 REMARK 500 ASN C 337 -91.49 -124.17 REMARK 500 LYS C 338 56.99 -165.86 REMARK 500 CYS C 339 -54.39 -121.52 REMARK 500 HIS C 343 74.80 -150.85 REMARK 500 TRP C 369 87.91 -151.37 REMARK 500 ALA C 370 -37.86 -39.15 REMARK 500 THR C 393 68.17 31.12 REMARK 500 GLN D 137 -31.30 -37.67 REMARK 500 SER D 164 -41.77 -131.05 REMARK 500 ARG E 169 -39.90 -130.37 REMARK 500 GLU E 223 -176.33 -174.88 REMARK 500 VAL E 233 149.40 -177.25 REMARK 500 GLU E 245 59.96 29.91 REMARK 500 GLN E 256 -37.65 -156.08 REMARK 500 ASP E 257 -156.63 -126.14 REMARK 500 THR E 280 79.52 -110.05 REMARK 500 ASP E 281 111.13 28.23 REMARK 500 REMARK 500 THIS ENTRY HAS 69 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 2 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 381 OD1 REMARK 620 2 ASP B 381 OD2 49.9 REMARK 620 3 ASP B 383 OD1 82.3 131.9 REMARK 620 4 ASP B 383 OD2 52.7 92.1 46.5 REMARK 620 5 TRP B 385 O 151.9 154.6 70.6 101.1 REMARK 620 6 HOH B 497 O 91.5 92.4 94.1 124.3 97.7 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA C 1 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 318 OD1 REMARK 620 2 ASP C 318 OD2 49.1 REMARK 620 3 ASP C 320 OD1 77.1 96.8 REMARK 620 4 PHE C 322 O 156.9 140.3 80.3 REMARK 620 5 GLY C 324 O 119.0 72.6 96.3 68.5 REMARK 620 6 HOH C 428 O 67.4 114.5 81.2 104.2 172.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 2 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP E 381 OD1 REMARK 620 2 ASP E 381 OD2 49.4 REMARK 620 3 ASP E 383 OD1 75.0 124.1 REMARK 620 4 TRP E 385 O 155.5 144.2 85.6 REMARK 620 5 HOH E 516 O 101.7 87.6 112.4 99.6 REMARK 620 6 HOH E 534 O 127.0 77.7 156.0 70.5 75.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA F 1 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP F 318 OD2 REMARK 620 2 ASP F 318 OD1 51.4 REMARK 620 3 ASP F 320 OD1 102.7 79.6 REMARK 620 4 PHE F 322 O 153.3 145.2 71.3 REMARK 620 5 GLY F 324 O 72.0 120.9 99.7 83.2 REMARK 620 6 HOH F 414 O 127.7 76.7 70.0 75.7 158.6 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D REMARK 900 RELATED ID: 1FZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D REMARK 900 RELATED ID: 1FZC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO REMARK 900 DIFFERENT BOUND LIGANDS REMARK 900 RELATED ID: 1FZE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN REMARK 900 RELATED ID: 1FZF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE REMARK 900 PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE REMARK 900 RELATED ID: 1FZG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE REMARK 900 PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE REMARK 900 RELATED ID: 1LT9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D DBREF 1LTJ A 126 191 UNP P02671 FIBA_HUMAN 145 210 DBREF 1LTJ D 126 191 UNP P02671 FIBA_HUMAN 145 210 DBREF 1LTJ B 149 461 UNP P02675 FIBB_HUMAN 179 491 DBREF 1LTJ E 149 461 UNP P02675 FIBB_HUMAN 179 491 DBREF 1LTJ C 96 406 UNP P02679 FIBG_HUMAN 122 432 DBREF 1LTJ F 96 406 UNP P02679 FIBG_HUMAN 122 432 DBREF 1LTJ G 1 4 PDB 1LTJ 1LTJ 1 4 DBREF 1LTJ H 1 4 PDB 1LTJ 1LTJ 1 4 DBREF 1LTJ I 1 4 PDB 1LTJ 1LTJ 1 4 DBREF 1LTJ J 1 4 PDB 1LTJ 1LTJ 1 4 SEQRES 1 A 66 VAL ILE GLU LYS VAL GLN HIS ILE GLN LEU LEU GLN LYS SEQRES 2 A 66 ASN VAL ARG ALA GLN LEU VAL ASP MET LYS ARG LEU GLU SEQRES 3 A 66 VAL ASP ILE ASP ILE LYS ILE ARG SER CYS ARG GLY SER SEQRES 4 A 66 CYS SER ARG ALA LEU ALA ARG GLU VAL ASP LEU LYS ASP SEQRES 5 A 66 TYR GLU ASP GLN GLN LYS GLN LEU GLU GLN VAL ILE ALA SEQRES 6 A 66 LYS SEQRES 1 B 313 HIS GLN LEU TYR ILE ASP GLU THR VAL ASN SER ASN ILE SEQRES 2 B 313 PRO THR ASN LEU ARG VAL LEU ARG SER ILE LEU GLU ASN SEQRES 3 B 313 LEU ARG SER LYS ILE GLN LYS LEU GLU SER ASP VAL SER SEQRES 4 B 313 ALA GLN MET GLU TYR CYS ARG THR PRO CYS THR VAL SER SEQRES 5 B 313 CYS ASN ILE PRO VAL VAL SER GLY LYS GLU CYS GLU GLU SEQRES 6 B 313 ILE ILE ARG LYS GLY GLY GLU THR SER GLU MET TYR LEU SEQRES 7 B 313 ILE GLN PRO ASP SER SER VAL LYS PRO TYR ARG VAL TYR SEQRES 8 B 313 CYS ASP MET ASN THR GLU ASN GLY GLY TRP THR VAL ILE SEQRES 9 B 313 GLN ASN ARG GLN ASP GLY SER VAL ASP PHE GLY ARG LYS SEQRES 10 B 313 TRP ASP PRO TYR LYS GLN GLY PHE GLY ASN VAL ALA THR SEQRES 11 B 313 ASN THR ASP GLY LYS ASN TYR CYS GLY LEU PRO GLY GLU SEQRES 12 B 313 TYR TRP LEU GLY ASN ASP LYS ILE SER GLN LEU THR ARG SEQRES 13 B 313 MET GLY PRO THR GLU LEU LEU ILE GLU MET GLU ASP TRP SEQRES 14 B 313 LYS GLY ASP LYS VAL LYS ALA HIS TYR GLY GLY PHE THR SEQRES 15 B 313 VAL GLN ASN GLU ALA ASN LYS TYR GLN ILE SER VAL ASN SEQRES 16 B 313 LYS TYR ARG GLY THR ALA GLY ASN ALA LEU MET ASP GLY SEQRES 17 B 313 ALA SER GLN LEU MET GLY GLU ASN ARG THR MET THR ILE SEQRES 18 B 313 HIS ASN GLY MET PHE PHE SER THR TYR ASP ARG ASP ASN SEQRES 19 B 313 ASP GLY TRP LEU THR SER ASP PRO ARG LYS GLN CYS SER SEQRES 20 B 313 LYS GLU ASP GLY GLY GLY TRP TRP TYR ASN ARG CYS HIS SEQRES 21 B 313 ALA ALA ASN PRO ASN GLY ARG TYR TYR TRP GLY GLY GLN SEQRES 22 B 313 TYR THR TRP ASP MET ALA LYS HIS GLY THR ASP ASP GLY SEQRES 23 B 313 VAL VAL TRP MET ASN TRP LYS GLY SER TRP TYR SER MET SEQRES 24 B 313 ARG LYS MET SER MET LYS ILE ARG PRO PHE PHE PRO GLN SEQRES 25 B 313 GLN SEQRES 1 C 311 TYR GLU ALA SER ILE LEU THR HIS ASP SER SER ILE ARG SEQRES 2 C 311 TYR LEU GLN GLU ILE TYR ASN SER ASN ASN GLN LYS ILE SEQRES 3 C 311 VAL ASN LEU LYS GLU LYS VAL ALA GLN LEU GLU ALA GLN SEQRES 4 C 311 CYS GLN GLU PRO CYS LYS ASP THR VAL GLN ILE HIS ASP SEQRES 5 C 311 ILE THR GLY LYS ASP CYS GLN ASP ILE ALA ASN LYS GLY SEQRES 6 C 311 ALA LYS GLN SER GLY LEU TYR PHE ILE LYS PRO LEU LYS SEQRES 7 C 311 ALA ASN GLN GLN PHE LEU VAL TYR CYS GLU ILE ASP GLY SEQRES 8 C 311 SER GLY ASN GLY TRP THR VAL PHE GLN LYS ARG LEU ASP SEQRES 9 C 311 GLY SER VAL ASP PHE LYS LYS ASN TRP ILE GLN TYR LYS SEQRES 10 C 311 GLU GLY PHE GLY HIS LEU SER PRO THR GLY THR THR GLU SEQRES 11 C 311 PHE TRP LEU GLY ASN GLU LYS ILE HIS LEU ILE SER THR SEQRES 12 C 311 GLN SER ALA ILE PRO TYR ALA LEU ARG VAL GLU LEU GLU SEQRES 13 C 311 ASP TRP ASN GLY ARG THR SER THR ALA ASP TYR ALA MET SEQRES 14 C 311 PHE LYS VAL GLY PRO GLU ALA ASP LYS TYR ARG LEU THR SEQRES 15 C 311 TYR ALA TYR PHE ALA GLY GLY ASP ALA GLY ASP ALA PHE SEQRES 16 C 311 ASP GLY PHE ASP PHE GLY ASP ASP PRO SER ASP LYS PHE SEQRES 17 C 311 PHE THR SER HIS ASN GLY MET GLN PHE SER THR TRP ASP SEQRES 18 C 311 ASN ASP ASN ASP LYS PHE GLU GLY ASN CYS ALA GLU GLN SEQRES 19 C 311 ASP GLY SER GLY TRP TRP MET ASN LYS CYS HIS ALA GLY SEQRES 20 C 311 HIS LEU ASN GLY VAL TYR TYR GLN GLY GLY THR TYR SER SEQRES 21 C 311 LYS ALA SER THR PRO ASN GLY TYR ASP ASN GLY ILE ILE SEQRES 22 C 311 TRP ALA THR TRP LYS THR ARG TRP TYR SER MET LYS LYS SEQRES 23 C 311 THR THR MET LYS ILE ILE PRO PHE ASN ARG LEU THR ILE SEQRES 24 C 311 GLY GLU GLY GLN GLN HIS HIS LEU GLY GLY ALA LYS SEQRES 1 D 66 VAL ILE GLU LYS VAL GLN HIS ILE GLN LEU LEU GLN LYS SEQRES 2 D 66 ASN VAL ARG ALA GLN LEU VAL ASP MET LYS ARG LEU GLU SEQRES 3 D 66 VAL ASP ILE ASP ILE LYS ILE ARG SER CYS ARG GLY SER SEQRES 4 D 66 CYS SER ARG ALA LEU ALA ARG GLU VAL ASP LEU LYS ASP SEQRES 5 D 66 TYR GLU ASP GLN GLN LYS GLN LEU GLU GLN VAL ILE ALA SEQRES 6 D 66 LYS SEQRES 1 E 313 HIS GLN LEU TYR ILE ASP GLU THR VAL ASN SER ASN ILE SEQRES 2 E 313 PRO THR ASN LEU ARG VAL LEU ARG SER ILE LEU GLU ASN SEQRES 3 E 313 LEU ARG SER LYS ILE GLN LYS LEU GLU SER ASP VAL SER SEQRES 4 E 313 ALA GLN MET GLU TYR CYS ARG THR PRO CYS THR VAL SER SEQRES 5 E 313 CYS ASN ILE PRO VAL VAL SER GLY LYS GLU CYS GLU GLU SEQRES 6 E 313 ILE ILE ARG LYS GLY GLY GLU THR SER GLU MET TYR LEU SEQRES 7 E 313 ILE GLN PRO ASP SER SER VAL LYS PRO TYR ARG VAL TYR SEQRES 8 E 313 CYS ASP MET ASN THR GLU ASN GLY GLY TRP THR VAL ILE SEQRES 9 E 313 GLN ASN ARG GLN ASP GLY SER VAL ASP PHE GLY ARG LYS SEQRES 10 E 313 TRP ASP PRO TYR LYS GLN GLY PHE GLY ASN VAL ALA THR SEQRES 11 E 313 ASN THR ASP GLY LYS ASN TYR CYS GLY LEU PRO GLY GLU SEQRES 12 E 313 TYR TRP LEU GLY ASN ASP LYS ILE SER GLN LEU THR ARG SEQRES 13 E 313 MET GLY PRO THR GLU LEU LEU ILE GLU MET GLU ASP TRP SEQRES 14 E 313 LYS GLY ASP LYS VAL LYS ALA HIS TYR GLY GLY PHE THR SEQRES 15 E 313 VAL GLN ASN GLU ALA ASN LYS TYR GLN ILE SER VAL ASN SEQRES 16 E 313 LYS TYR ARG GLY THR ALA GLY ASN ALA LEU MET ASP GLY SEQRES 17 E 313 ALA SER GLN LEU MET GLY GLU ASN ARG THR MET THR ILE SEQRES 18 E 313 HIS ASN GLY MET PHE PHE SER THR TYR ASP ARG ASP ASN SEQRES 19 E 313 ASP GLY TRP LEU THR SER ASP PRO ARG LYS GLN CYS SER SEQRES 20 E 313 LYS GLU ASP GLY GLY GLY TRP TRP TYR ASN ARG CYS HIS SEQRES 21 E 313 ALA ALA ASN PRO ASN GLY ARG TYR TYR TRP GLY GLY GLN SEQRES 22 E 313 TYR THR TRP ASP MET ALA LYS HIS GLY THR ASP ASP GLY SEQRES 23 E 313 VAL VAL TRP MET ASN TRP LYS GLY SER TRP TYR SER MET SEQRES 24 E 313 ARG LYS MET SER MET LYS ILE ARG PRO PHE PHE PRO GLN SEQRES 25 E 313 GLN SEQRES 1 F 311 TYR GLU ALA SER ILE LEU THR HIS ASP SER SER ILE ARG SEQRES 2 F 311 TYR LEU GLN GLU ILE TYR ASN SER ASN ASN GLN LYS ILE SEQRES 3 F 311 VAL ASN LEU LYS GLU LYS VAL ALA GLN LEU GLU ALA GLN SEQRES 4 F 311 CYS GLN GLU PRO CYS LYS ASP THR VAL GLN ILE HIS ASP SEQRES 5 F 311 ILE THR GLY LYS ASP CYS GLN ASP ILE ALA ASN LYS GLY SEQRES 6 F 311 ALA LYS GLN SER GLY LEU TYR PHE ILE LYS PRO LEU LYS SEQRES 7 F 311 ALA ASN GLN GLN PHE LEU VAL TYR CYS GLU ILE ASP GLY SEQRES 8 F 311 SER GLY ASN GLY TRP THR VAL PHE GLN LYS ARG LEU ASP SEQRES 9 F 311 GLY SER VAL ASP PHE LYS LYS ASN TRP ILE GLN TYR LYS SEQRES 10 F 311 GLU GLY PHE GLY HIS LEU SER PRO THR GLY THR THR GLU SEQRES 11 F 311 PHE TRP LEU GLY ASN GLU LYS ILE HIS LEU ILE SER THR SEQRES 12 F 311 GLN SER ALA ILE PRO TYR ALA LEU ARG VAL GLU LEU GLU SEQRES 13 F 311 ASP TRP ASN GLY ARG THR SER THR ALA ASP TYR ALA MET SEQRES 14 F 311 PHE LYS VAL GLY PRO GLU ALA ASP LYS TYR ARG LEU THR SEQRES 15 F 311 TYR ALA TYR PHE ALA GLY GLY ASP ALA GLY ASP ALA PHE SEQRES 16 F 311 ASP GLY PHE ASP PHE GLY ASP ASP PRO SER ASP LYS PHE SEQRES 17 F 311 PHE THR SER HIS ASN GLY MET GLN PHE SER THR TRP ASP SEQRES 18 F 311 ASN ASP ASN ASP LYS PHE GLU GLY ASN CYS ALA GLU GLN SEQRES 19 F 311 ASP GLY SER GLY TRP TRP MET ASN LYS CYS HIS ALA GLY SEQRES 20 F 311 HIS LEU ASN GLY VAL TYR TYR GLN GLY GLY THR TYR SER SEQRES 21 F 311 LYS ALA SER THR PRO ASN GLY TYR ASP ASN GLY ILE ILE SEQRES 22 F 311 TRP ALA THR TRP LYS THR ARG TRP TYR SER MET LYS LYS SEQRES 23 F 311 THR THR MET LYS ILE ILE PRO PHE ASN ARG LEU THR ILE SEQRES 24 F 311 GLY GLU GLY GLN GLN HIS HIS LEU GLY GLY ALA LYS SEQRES 1 G 4 GLY PRO ARG PRO SEQRES 1 H 4 GLY HIS ARG PRO SEQRES 1 I 4 GLY PRO ARG PRO SEQRES 1 J 4 GLY HIS ARG PRO MODRES 1LTJ ASN B 364 ASN GLYCOSYLATION SITE MODRES 1LTJ ASN E 364 ASN GLYCOSYLATION SITE HET NAG K 1 14 HET NAG K 2 14 HET FUC K 3 10 HET NAG L 1 14 HET NAG L 2 14 HET FUC L 3 10 HET CA B 2 1 HET CA C 1 1 HET CA E 2 1 HET CA F 1 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CA CALCIUM ION FORMUL 11 NAG 4(C8 H15 N O6) FORMUL 11 FUC 2(C6 H12 O5) FORMUL 13 CA 4(CA 2+) FORMUL 17 HOH *250(H2 O) HELIX 1 1 ILE A 127 CYS A 161 1 35 HELIX 2 2 LYS A 176 ALA A 190 1 15 HELIX 3 3 THR B 163 CYS B 193 1 31 HELIX 4 4 GLU B 210 ARG B 216 1 7 HELIX 5 5 THR B 244 ASN B 246 5 3 HELIX 6 6 LYS B 265 GLN B 271 1 7 HELIX 7 7 ASN B 296 MET B 305 1 10 HELIX 8 8 GLU B 334 ASN B 336 5 3 HELIX 9 9 ALA B 352 ASP B 355 1 4 HELIX 10 10 MET B 361 THR B 368 1 8 HELIX 11 11 MET B 438 GLY B 442 1 5 HELIX 12 12 ILE C 100 GLN C 134 1 35 HELIX 13 13 CYS C 153 ALA C 157 1 5 HELIX 14 14 ASN C 207 GLU C 213 1 7 HELIX 15 15 ASN C 230 SER C 237 1 8 HELIX 16 16 GLU C 270 ASP C 272 5 3 HELIX 17 17 ALA C 289 ASP C 291 5 3 HELIX 18 18 ASP C 301 PHE C 304 1 4 HELIX 19 19 CYS C 326 ASP C 330 1 5 HELIX 20 20 LYS C 356 SER C 358 5 3 HELIX 21 21 ILE D 133 CYS D 161 1 29 HELIX 22 22 LYS D 176 ALA D 190 1 15 HELIX 23 23 ARG E 169 ARG E 194 1 26 HELIX 24 24 GLU E 210 ARG E 216 1 7 HELIX 25 25 THR E 244 ASN E 246 5 3 HELIX 26 26 LYS E 265 GLN E 271 1 7 HELIX 27 27 ASN E 296 MET E 305 1 10 HELIX 28 28 GLU E 334 ASN E 336 5 3 HELIX 29 29 ALA E 352 ASP E 355 1 4 HELIX 30 30 MET E 361 THR E 368 1 8 HELIX 31 31 MET E 438 GLY E 442 1 5 HELIX 32 32 LEU F 110 GLN F 134 1 25 HELIX 33 33 CYS F 153 ASN F 158 1 6 HELIX 34 34 ASN F 207 GLU F 213 1 7 HELIX 35 35 ASN F 230 SER F 237 1 8 HELIX 36 36 GLU F 270 ASP F 272 5 3 HELIX 37 37 ALA F 289 ASP F 291 5 3 HELIX 38 38 ASP F 301 PHE F 304 1 4 HELIX 39 39 CYS F 326 ASP F 330 1 5 HELIX 40 40 LYS F 356 SER F 358 5 3 SHEET 1 A 2 GLU B 223 ILE B 227 0 SHEET 2 A 2 TYR B 236 CYS B 240 -1 N CYS B 240 O GLU B 223 SHEET 1 B 2 GLY B 272 GLY B 274 0 SHEET 2 B 2 TYR B 292 LEU B 294 -1 N TRP B 293 O PHE B 273 SHEET 1 C 5 TYR B 345 GLY B 347 0 SHEET 2 C 5 LYS B 321 TYR B 326 -1 N HIS B 325 O ARG B 346 SHEET 3 C 5 GLU B 309 GLU B 315 -1 N MET B 314 O VAL B 322 SHEET 4 C 5 LYS B 449 ARG B 455 -1 N ARG B 455 O GLU B 309 SHEET 5 C 5 THR B 250 ARG B 255 -1 N ARG B 255 O MET B 450 SHEET 1 D 2 GLY B 328 VAL B 331 0 SHEET 2 D 2 ILE B 340 ASN B 343 -1 N ASN B 343 O GLY B 328 SHEET 1 E 6 GLY C 165 ILE C 169 0 SHEET 2 E 6 PHE C 178 ILE C 184 -1 N CYS C 182 O GLY C 165 SHEET 3 E 6 GLY C 190 ARG C 197 -1 N TRP C 191 O GLU C 183 SHEET 4 E 6 LYS C 381 PRO C 388 -1 N ILE C 386 O THR C 192 SHEET 5 E 6 TYR C 244 GLU C 251 -1 N GLU C 251 O LYS C 381 SHEET 6 E 6 THR C 257 ALA C 263 -1 N TYR C 262 O LEU C 246 SHEET 1 F 2 GLU E 223 ILE E 227 0 SHEET 2 F 2 TYR E 236 CYS E 240 -1 N CYS E 240 O GLU E 223 SHEET 1 G 2 GLY E 272 GLY E 274 0 SHEET 2 G 2 TYR E 292 LEU E 294 -1 N TRP E 293 O PHE E 273 SHEET 1 H 5 TYR E 345 GLY E 347 0 SHEET 2 H 5 LYS E 321 TYR E 326 -1 N HIS E 325 O ARG E 346 SHEET 3 H 5 GLU E 309 GLU E 315 -1 N MET E 314 O VAL E 322 SHEET 4 H 5 LYS E 449 ARG E 455 -1 N ARG E 455 O GLU E 309 SHEET 5 H 5 THR E 250 ARG E 255 -1 N ARG E 255 O MET E 450 SHEET 1 I 2 GLY E 328 VAL E 331 0 SHEET 2 I 2 ILE E 340 ASN E 343 -1 N ASN E 343 O GLY E 328 SHEET 1 J 7 GLY F 165 ILE F 169 0 SHEET 2 J 7 PHE F 178 ILE F 184 -1 N CYS F 182 O GLY F 165 SHEET 3 J 7 GLY F 190 ARG F 197 -1 N VAL F 193 O TYR F 181 SHEET 4 J 7 LYS F 381 PRO F 388 -1 N ILE F 386 O THR F 192 SHEET 5 J 7 TYR F 244 GLU F 251 -1 N GLU F 251 O LYS F 381 SHEET 6 J 7 THR F 257 ALA F 263 -1 N TYR F 262 O LEU F 246 SHEET 7 J 7 TYR F 280 GLY F 283 -1 N GLY F 283 O ASP F 261 SSBOND 1 CYS A 161 CYS C 135 1555 1555 2.03 SSBOND 2 CYS A 165 CYS B 193 1555 1555 2.03 SSBOND 3 CYS B 197 CYS C 139 1555 1555 2.03 SSBOND 4 CYS B 201 CYS B 286 1555 1555 2.03 SSBOND 5 CYS B 211 CYS B 240 1555 1555 2.03 SSBOND 6 CYS B 394 CYS B 407 1555 1555 2.03 SSBOND 7 CYS C 153 CYS C 182 1555 1555 2.03 SSBOND 8 CYS C 326 CYS C 339 1555 1555 2.03 SSBOND 9 CYS D 161 CYS F 135 1555 1555 2.03 SSBOND 10 CYS D 165 CYS E 193 1555 1555 2.04 SSBOND 11 CYS E 197 CYS F 139 1555 1555 2.03 SSBOND 12 CYS E 201 CYS E 286 1555 1555 2.03 SSBOND 13 CYS E 211 CYS E 240 1555 1555 2.03 SSBOND 14 CYS E 394 CYS E 407 1555 1555 2.04 SSBOND 15 CYS F 153 CYS F 182 1555 1555 2.03 SSBOND 16 CYS F 326 CYS F 339 1555 1555 2.04 LINK ND2 ASN B 364 C1 NAG K 1 1555 1555 1.45 LINK ND2 ASN E 364 C1 NAG L 1 1555 1555 1.45 LINK O4 NAG K 1 C1 NAG K 2 1555 1555 1.39 LINK O6 NAG K 1 C1 FUC K 3 1555 1555 1.40 LINK O4 NAG L 1 C1 NAG L 2 1555 1555 1.39 LINK O6 NAG L 1 C1 FUC L 3 1555 1555 1.41 LINK CA CA B 2 OD1 ASP B 381 1555 1555 2.67 LINK CA CA B 2 OD2 ASP B 381 1555 1555 2.55 LINK CA CA B 2 OD1 ASP B 383 1555 1555 2.37 LINK CA CA B 2 OD2 ASP B 383 1555 1555 2.98 LINK CA CA B 2 O TRP B 385 1555 1555 2.46 LINK CA CA B 2 O HOH B 497 1555 1555 2.32 LINK CA CA C 1 OD1 ASP C 318 1555 1555 2.62 LINK CA CA C 1 OD2 ASP C 318 1555 1555 2.66 LINK CA CA C 1 OD1 ASP C 320 1555 1555 2.46 LINK CA CA C 1 O PHE C 322 1555 1555 2.08 LINK CA CA C 1 O GLY C 324 1555 1555 2.41 LINK CA CA C 1 O HOH C 428 1555 1555 2.32 LINK CA CA E 2 OD1 ASP E 381 1555 1555 2.61 LINK CA CA E 2 OD2 ASP E 381 1555 1555 2.60 LINK CA CA E 2 OD1 ASP E 383 1555 1555 2.27 LINK CA CA E 2 O TRP E 385 1555 1555 2.53 LINK CA CA E 2 O HOH E 516 1555 1555 2.82 LINK CA CA E 2 O HOH E 534 1555 1555 2.50 LINK CA CA F 1 OD2 ASP F 318 1555 1555 2.66 LINK CA CA F 1 OD1 ASP F 318 1555 1555 2.36 LINK CA CA F 1 OD1 ASP F 320 1555 1555 2.28 LINK CA CA F 1 O PHE F 322 1555 1555 2.38 LINK CA CA F 1 O GLY F 324 1555 1555 2.26 LINK CA CA F 1 O HOH F 414 1555 1555 2.47 CISPEP 1 ARG B 406 CYS B 407 0 -0.85 CISPEP 2 LYS C 338 CYS C 339 0 0.03 CISPEP 3 ARG E 406 CYS E 407 0 0.28 CISPEP 4 LYS F 338 CYS F 339 0 0.15 CRYST1 89.284 94.218 226.936 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011200 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010614 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004407 0.00000